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Cortical distribution of prostaglandin and renin in isolated dog glomer.
uli. This study was performed (1) to evaluate the ability of renal
superficial (SP) and juxtamedullary (JM) isolated glomeruli to synthe-
size 6-keto-prostaglandin F1, (6-keto-PGF1) and prostaglandin E2
(POE2) when stimulated with different doses of arachidonic acid (AA)
and (2) to determine the differential effects that the formation of these
prostaglandins may have on renin release. Renal SP and JM glomeruli
were isolated separately from dog renal cortex using a passive sieving
technique. Glomeruli were superfused within glass chambers with a
Krebs Ringer solution and three different concentrations of AA. Efflu-
ent concentrations of 6-keto-PGF1, (primary metabolite of P0!2),
PGE2, and renin were determined by radioimmunoassay. Synthesis of
6-keto-PGF1,, by SP glomeruli increased in a dose-dependent manner in
response to the three increasing concentrations of AA. These three
doses of AA also evoked proportional increments in the release of renin
which were significantly correlated with the increases in 6-keto-PGF.
In contrast, PGE2 synthesis was maximally stimulated by all doses of
AA and was not correlated with renin release. !n JM glomeruli, AA
evoked the same pattern in the synthesis of 6-keto-PGF1 and PGE2.
However, renin release increased significantly only with the perfusion
of the highest concentration of AA. These perfusion results show that
SP and JM glomeruli have the same ability to synthesize 6-keto-PGF1
and PGE2. However, renin release was significantly higher in SP than in
JM glomeruli and correlated with 6-keto-PGF1, synthesis.
Distribution corticale de prostaglandines et de rénine dans des glomér-
ules isolés de chiens. Cette étude a ëtë effectuée (I) afin d'évaluer Ia
capacité des glomérules isolés superficiels (SP) ou juxtamédullaires
(JM) de synthétiser de Ia 6-kéto-prostaglandine F1 (6-kéto-PGF,) et de
Ia prostaglandine E2 (PGE2) après stimulation avec différentes doses
d'acide arachidonique (AA) et (2) pour determiner les différents effets
que Ia formation de ces prostanglandines pourrait entrainer sur Ic
relargage de Ia refine. Des glomerules rénaux SP et JM ont ete isolés
séparément a partir de cortex renal de chiens, en utilisant une technique
de filtration passive. Les glomerules ont été périfusés dans des cham-
bres en verre avec une solution de Krebs-Ringer et trois concentrations
différentes d'AA. Les concentrations effluentes de 6-kéto-PGF1,,
(métabolites primaires de PGI2), de PGE2, et de rénine ont été deter-
minées par dosage radioimmunologique. La synthése de 6-kéto-PGF1,,
par les glomerules SP s'élevait d'une facon dépendante de Ia dose en
réponse aux trois concentrations croissantes d'AA. Ces trois concen-
trations d'AA entrainaient également des augmentations proportion-
nelles dans Ic relargage de Ia refine, qui étaient significativement
corrélées avec les élCvations de 6-kéto-PGF1. A l'oppose, Ia synthese
de POE2 était stimulée de facon maximale par toutes les doses de AA,
et n'était par corrClée au relargage de rénine. Dans les glomerules JM,
AA entrainait le méme type de synthese de 6-kéto-PGF1 et POE2.
Cependant, le relargage de refine ne s'élevait significativement que lors
de Ia perfusion avec Ia plus forte concentration de AA. Ces résultats de
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perfusion montrent que les glomérules SP et JM ont Ia même capacitC
de synthetiser de Ia 6-kéto-PGF1,, et dans la POE2. Cependant, Ic
relargage de Ia rénine était significativement plus élevé dans les
glomCrules SP que JM et était corrélé avec La synthése de 6-kCto-PGF1,.
The concept of nephron heterogeneity has been suggested by
both morphological and physiological evidences [1]. The natu-
rally occurring compounds that may be involved in the regula-
tion of RBF distribution and/or glomerular dynamics have not
yet been fully identified. However, most of the research efforts
have been centered around the renin-angiotensin and prosta-
glandin systems because the infusion of these vasoactive sub-
stances has proved to alter glomerular dynamics [2] and blood
flow distributions [3, 4]. In this regard, we have previously
shown that the synthesis of prostaglandins (PG's) plays an
important role in mediating the release of renin in isolated rat
glomeruli and that this renin-releasing effect of PG's appears to
be exerted through a pathway different from that used by beta-
adrenoreceptor agonists [5]. More recently we reported that
isolated rat glomeruli are capable of synthesizing all primary
PG's and that the AA-stimulated renin release operates via
PGI2 (as represented by 6-keto-PGF,a) synthesis because other
PG's failed to stimulate renin in a comparable manner [6].
The present study was designed to evaluate the possible
differential ability of the superficial (SP) and juxtamedullary
(JM) dog glomeruli to synthesize 6-keto-PGF1, and release
renin when stimulated with different concentrations of AA. For
comparative purposes, PGE2 was also measured because previ-
ous studies have shown that this prostaglandin constitutes a
major product of AA stimulation in the glomeruli.
Methods
Isolation of glomeruli
Mongrel dogs weighing 14 to 16 kg, were anesthetized
intravenously with sodium pentobarbital (30 mg/kg body wt,
Fort Dodge Laboratories, Inc.). The renal arteries were cathe-
terized through flank incisions. The renal veins were tied off
and slit to allow the kidneys to be flushed of blood using an
aerated (95% 02/5% C02) modified Krebs-Ringer Tris buffer
(140 mit NaC1; 5 mrt KCI, 0.8 m'i Mg504, 2 mrvi CaCI2, 10 mM
NaAc, 10 mM glucose, 20 mrt Tris base, 2 m Na P04, pH 7.4).
The kidneys were then excised and decapsulated; the cortices
were dissected free. The cortex was conventionally divided into
three proportional sections; an outer or SP zone, an intermedi-
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Fig. 1. Scanning electron micro graph of an
isolaied rat, left, and dog, right, glomerulus.
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Fig. 2. Glass perfusion chamber with scintered glass filters at either end
used to contain isolated glomeruli.
ate zone, and an inner, JM zone. Tissue of the intermediate
zone was discarded. Glomeruli from the SP and JM zones were
isolated separately using a passive sieving technique similar to
that used in previous studies [5].
The cortical SP or JM tissue samples were pressed through a
60 mesh (250 tm) stainless steel sieve and collected in a beaker.
The sieved tissue suspended in Krebs was drawn into a syringe
through a 21-gauge needle and then ejected into 17 x 100 mm
polyethylene tubes for centrifugation at x l6Og for 2 mm at
room temperature. The pellet was resuspended in Krebs and
centrifuged two more times discarding the supernatant each
time. The pellet was again suspended in Krebs and poured
progressively through a series of Nitex monofilament screens of
48 mesh (390 sm), 72 mesh (250 ®m), and 80 mesh (212 gm),
respectively. These screens, filtering out tubular elements and
other large tissue fragments, were discarded. The filtered
suspension of glomeruli was placed on a 200 mesh (60 m)
screen. The glomeruli recovered were rinsed again through an
80 mesh screen to remove the remaining tubular fragments.
They were centrifuged in preweighed polyethylene tubes at
x 750g for 5 mm; the supernatants were decanted. A sample
was collected from each tube and viewed under a microscope
(x400) to check the purity of the preparation. Glomerular
suspensions were accepted when no more than three tubular
fragments appeared per 100 glomeruli. During the very initial
experiments, controls for purity were also performed by scan-
ning electron microscopy (xl,000). This procedure was per-
formed to compare relative diameters of rat and dog glomeruli
to adjust the pore size of the sieves (Fig. 1). The viability of the
glomerular preparation was evaluated by determining the pres-
ence of lactate dehydrogenase (LDH) in the supernatant of
glomerular incubations (100 mg of protein/ml) or by the uptake
of trypan blue. The LDH levels were negligible when compared
to those obtained after incubation with trypsin; and, as well, the
uptake of trypan blue was essentially nonexistent, even after 90
mm of perfusion, with or without the 10' arachidonic acid
stimulation.
Superfusion methodology
After the last centrifugation, the tubes were blotted dry and
reweighed. Glomeruli, 40 to 50 mg (wet weight), were placed in
a glass chamber designed by the Engineering Department of the
Mayo Foundation (Fig. 2), As shown, each chamber consists of
two identical ends held together by a connector (Teflon®). Both
ends of the chamber are occluded with scintered glass filters
that entrap the glomeruli while allowing free perfusion. In this
preparation there are approximately 500 glomeruli/mg wet wt of
the glomerular suspension. Since 50 mg wet wt of glomeruli
were used in each chamber, it was calculated that 25,000
glomeruli were perfused in each chamber. Krebs buffer continu-
ously aerated with 95% 02/5% CO2 maintained at 37°C by a
heater (Temp-Block, McGraw Park, Illinois) was superfused
through the chambers containing glomeruli by a polystatic
pump (model 3-6100, Buchler, Fort Lee, New Jersey). The
chamber effluent was drained via tubing (Teflon®) into a micro-
fractionator (Gilson FC-800, Middleton, Wisconsin) and col-
lected in 10-mm periods at a rate of 0.3 mI/mm. Under these
conditions, glomeruli were allowed to stabilize during 30 mm of
perfusion after which a 10-mm control period was collected.
This control period was followed by a fifth 10-mm period during
which the glomeruli were superfused with a Krebs solution
containing one of the following agents:
• Arachidonic acid (Nu-Chek, Inc., Elysian, Minnesota) di-
luted in 100 mivi NaCO3, pH = 11.0, and mixed in a refrigerator
for 2 hr was perfused at a concentration of 1.6 X iO M, N =6.
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• Arachidonic acid, at a concentration of 3.2 X i0 M, N =
• Arachidonic acid, at a concentration of 1.6 X i0 M, N =
• In additional experiments AA was perfused at a concentra-
tion of 1.6 x io- M,N = 2, and 1.6 x 106 M, N = 2, to define
the minimum stimulating levels for PGE2 synthesis.
• Meclofenamate at a concentration of 6.3 x 1O M was
perfused 20 mm prior to starting infusions of arachidonic acid,
N = 2.
Following the administration of each agent, superfusion with
Krebs medium alone was resumed for an additional 40 mm and
collected in 10-mm fractions.
Chemical determinations
Recovery of AA in perfusate. The loss of AA within the
superfusion system was estimated by superfusing [1-'4C] AA
and determining its concentration in the effluent exiting the
chamber. These losses were approximately 60% of the amount
initially superfused, contrasting with the 90 to 92% recovery of
[3H] 6-keto-PGF1a and [3H] PGE2 (New England Nuclear
Corporation, Boston, Massachusetts) when the PG's were
injected directly into the glass chambers and recovered in the
effluent by the microfractionator. This indicates that (1) the
superfused glomeruli are exposed to much less AA than that
contained in the initial solution and (2) the amount of PG's
reaching the microfractionator is truly reflecting the concentra-
tion of PG's synthesized by the glomeruli. The reported results
are not corrected for these losses.
Measurement of renin concentration in the perfusate. Renin
concentrations were determined by radioimmunoassay in each
of the 3-mi effluent fractions collected every 10 mm. The
specific procedures used for these determinations are compara-
ble to those previously used in the rat [61 and are outlined
below.
For each 3-mi fraction, a 50-gd aliquot was mixed with 50 j.d
of sodium phosphate buffer (50 m'vi, pH 7.4) [7], 10 d 8-
hydroxyquinoline, 10 d dimercaprol, and 10 d 3.8% EDTA.
One hundred microliters of nephrectomized dog plasma was
added as renin substrate for the generation of angiotensin I.
Estimation of angiotensin I generation from nephrectomized
dog plasma after total substrate consumption with excess hog
renin was performed according to the criteria established in
previous studies [8, 9]. One Goldblatt unit of commercially
available hog renin (Biochemical Nutritional Corp., Cleveland,
Ohio) diluted in 0.5 ml of sodium phosphate buffer containing
angiotensinase inhibitor, released 410 8 ng!ml of angioten sin
from 0.5 ml of dog nephrectomized plasma in 8 mm of incuba-
tion at 37°C; whereas twice as much angiotensin, 838 12
ng/ml, was generated when the amount of plasma was doubled
and the amount of enzyme was kept constant. Since incubation
of this plasma with renin released from glomeruli never exceed-
ed 30 ng/ml of perfusate, it was concluded that the total
substrate consumption was below 10% of the total substrate
available. This fulfills the requirements of enzyme maximal
velocity [9] and was subsequently proven in two experiments.
Linear formation of angiotensin I was observed during 1-hr
incubations of glomerular effluent fluid with dog nephrecto-
mized plasma. The amount of angiotensin formed at 15, 30, and
60 mm in the two experiments were 6, 13, and 23 ng/mllhr and 7,
13, and 28 ng/ml/hr, respectively. The coefficient of variability
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determined in duplicates of all renin samples for this study was
6.3 2%.
Determination of PGE2 and 6-keto-PGF,a in the perfusate.
Determinations of PGE2 and 6-keto-PGF1a in the glomerular
perfusate were performed by radioimmunoassay after organic
solvent extraction. For this purpose the remaining 2.5 ml of
perfusate were adjusted to pH 3.4 with 1 N citric acid and then
extracted twice with three volumes of chloroform:methanol
(2:1). After extraction, the pH of the sample was raised to pH
5.8—6.2 with 100 d 1 M phosphate buffer and blown dry under
nitrogen gas. Antibodies for PGE2 were obtained from Pasteur
Institute, Paris, France, while antibodies for 6-keto-PGF1 were
made in our laboratory. Cross-reactivity of these antibodies
with other prostanoids, arachidic acid, endoperoxide analog
H2, PGF2, PGD2, PGH2, PGE1, 13-14 dihydro-l5-keto-E2 and
F2, varied from 0 to 3%.
Cross-reactivity of PGE2 and 6-keto-PGF1a antisera with the
perfused arachidonic acid was studied by determining displace-
ment of tritiated PGE2 (New England Nuclear Corporation) and
6-keto-PGF1c. (New England Nuclear Corporation) bound to
their specific antibody when arachidonic acid concentration in
the incubation media was raised from 1 x l0 to 0.8 X l0 M.
However, above these levels 1.2 x lO M and 2.4 x l0- M
arachidonic acid produced 9 and 21% displacement. Such cross-
reactivity was detected when control chambers not containing
glomeruli were perfused with the highest dose of arachidonic
acid 1.6 x i0 M. In this case the percent cross-reactivity was
subtracted from values obtained for PGE2 and 6-keto-PGF1
radioimmunoassays. Total RIA recoveries for these prostaglan-
din assays ranged from 81 to 87% with a variation coefficient of
8.9%. Minimum detection levels of the assays vary from 3 to 4
pg/ml for PGE2 and 2.5 to 5 pg/mi for 6-keto-PGF1a. The
sensitivity of radioimmunoassay estimated as the minimal vari-
ation in the concentration of prostaglandins to produce 10%
displacement of each antibody within the steepest portion of the
curve varied from 8.1 to 12.3 pg/mI.
Furthermore, in two experiments the relative concentrations
of 6-keto-PGF1a (12,160 pg) and PGE2 (7,560 pg) in 18 ml of
perfusate pooled from six different chambers during the infu-
sion of maximal doses of AA and measured with radio-
immunoassay before and after separation with high perform-
ance liquid chromatography (HPLC) differs by 9 and 12%,
respectively. In addition, incubation of remaining fractions
after specific peak isolation of PGE2 or 6-keto-PGF10, with their
respective antibodies exhibited a cross-reactivity of less than
0.5% for PGE2 and less than 0.7% for 6-keto-PGF1a. In view of
this consistency and considering that direct quantitative HPLC
determinations of PG's in perfusate fluid were unfeasible since
minimum detection levels for PGE2 and 6-keto-PGF1 are 15
and 10 ng, respectively, (using isocratic elution and 30%
acetonitrile as mobile phase at a flow of 1.5 mlImin and UV
detection), we did not use HPLC in subsequent determinations.
Profile of glomerular prostaglandin synthesis from radiola-
belled[1-'4C1-arachidonic acid. As mentioned above, the perfu-
sion studies were designed to define the interrelationship be-
tween 6kCtOPGFia and the release of renin within SP and JM
glomeruli while PGE2 synthesis was being used to monitor
other prostanoids which were not being determined by radio-
immunoassay. These experiments, however, do not eliminate
the possible existence of significant differences in the produc-
tion of PGD2 and TxB2. For this purpose the prostaglandin
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generating activity in whole SP or JM glomeruli from [l-'4C]-
arachidonic acid was determined with a procedure identical to
that used in previous studies of whole rat glomeruli [6] and in
microsomal fraction of rat glomeruli [10]. The incubation mix-
ture consisted of 4 mg protein (approximately 100mg glomeruli)
as determined by Lowry's method [111, 3 d of [l-'4C]-arachi-
donic acid (56.4 mCi, 1.74 g AA, New England Nuclear
Corporation); the remaining volume was brought to 1 ml with
phosphate buffer. The mixture was incubated at 37°C for 30'. To
determine background activity, a blank mixture was prepared
without the glomeruli and incubated at 0°C for 30'. Then the
glomeruli were added. After the incubation, the radioactive
prostanoid products were separated by two developmental
phases of silica gel thin layer chromatography (TLC). The first
using an organic phase of ethyl acetate:n-hexane:acetic acid-
:water (57:26:12:60 vol/vollvol/vol) as a solvent system sepa-
rates all primary prostaglandins except PGE2 and TxB2. The
second using a solvent system of chloroform:methanol:acetic
acid (90:10:5 vollvol/vol) was run on a different silica gel TLC
plate to separate PGE2 and TxB2. In each case silica gel zones
containing each product were identified by comparison to a
simultaneously developed TLC plate of prostaglandin stan-
dards. Each of the separate zones was scraped, put in vials to
which scintillation fluid was added, and counted for radioactiv-
ity in a scintillation counter.
Determination of renin concentration in superficial and jux-
tamedullary glomeruli. SP and JM glomeruli were isolated from
three different dogs to determine renin concentration. After
isolation, 0.5 mg of SP and JM glomeruli from each dog was
suspended in 1 ml of Krebs Ringer solution and homogenized.
After centrifugation, the supernatant was separated and the
concentration of renin was estimated by incubating 10 d with
0.5 ml of nephrectomized dog plasma containing angiotensinase
inhibitors (dimercaprot, EDTA, and 8-hydroxyquinoline) for 4,
8, and 16 mm. The concentration of A! was measured by
radioimmunoassay. The results were expressed in nanograms
of angiotensin I formed per mi/SO mg of glomerular wet weight
per minute.
Statistical treatment
As mentioned under superfusion methodology the amount of
SP and JM glomeruli isolated from both kidneys of a dog was
sufficient to run a total of 12 chambers: four with SP glomeruli,
four with JM glomeruli, and four used as time or negative
controls. The stimulation of renin or PG's induced by the 10-
mm AA perfusion was calculated by measuring the maximal
increment in concentration of renin or PG above the basal
levels. Then the results of each group of four chambers per
animal were averaged. This average represents an N = 1.
Therefore the value of N given in this study represents the
number of animals rather than the number of chambers.
All values are presented as the mean 1 SE. Student's t test
for paired and unpaired variates was performed for analysis of
statistical significance. Results were considered significant
when P values were less than 0.05.
Results
Changes in actual concentrations of renin, 6-keto-PGF1,,, and
PGE2 in the glomerular perfusate during basal conditions and
the administration of different doses of arachidonic acid are
ii
1.6 x 104M 3.2 X 1O4M 1.6 x 103M
Fig. 3. Changes in the concentration of renin, 6-keto-PGF1,, and PGE2,
detected in the effluent fluid of superficial (open bars) and juxiame-
dullary (hatched bars) glomeruli when superfused with 1.6 x io (N =
6), 3.2 x io- (N = 5), and 1.6 >< 1O (N = 6) M arachidonic acid, as
calculated by maximal response less the basal level. The asterisk
represents P < 0.05.
shown in Table 1; delta differences between basal and arachi-
donic acid stimulations are depicted in Figure 3.
Superfusion
The basal levels of renin released from all SP glomeruli during
control periods were significantly greater than equivalent basal
renin values for JM glomeruli (5.52 1.02 vs. 2.01 0.47 ng
Al/ml/hr, P <0.001, N = 16). The basal concentrations of either
6-keto-PGF1a or PGE2 synthesized during control periods were
not different between SP and JM glomeruli.
Arachidonic acid at a concentration of 1.6 X io M.
Superfusion of SP glomeruli with 1.6 x l0- M AA had no effect
on renin release (8.9 2.6 to 8.3 0.7 ng AL/ml/hr, N = 6), nor
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Table 1. Renin, 6-keto-PGF1 and PGE2 concentrations in the glomerular perfusate during basal conditions and during peak stimulation with
arachidonic acid
Effluent concentration
Glomerular
zone Basal
AA
1.6 x 10 M Basal
AA
3.2 x 10 M Basal
AA
1.6 x I0 M
sp
Renin (Ang I), ng/mi/hr x SE
JM
X SE
sP
8.9 2.6
3.6 1.4
8.3
3.3
0.7
1.1
3.4
1.5
0.6
0.8
11.9a
2.0
3.7
0.5
3.9 2.0
1.1 0.2
24.9a 5.1
6.4a 0.9
6-keto-PGF1, pg/mi x SE
JM
X SE
sP
58 13
73 18
117
145
36
46
101
104
48
32
302k
l97a
115
48
64 20
52 10
894a 209
809a 154
PGE2, pg/mi x SE
JM
X SE
20 10
20 9
456a
450a
106
171
111
68
39
26
539a
235a
330
90
62 20
42 23
545a 214
545a 140
a P < 0.05.
was 6-keto-PGF1. significantly affected (58 13 to 117 36
pglml). However, PGE2 synthesis in SP glomeruli increased
from 20 10 to 456 106 pg/mI (P < 0.05).
Superfusion of JM glomeruli with the same concentration of
AA did not produce an effect on renin release (3.6 1.4 to 3.3
1.1 ng Al/ml/hr, N = 6) nor was there a significant change in the
synthesis of 6-keto-PGF1a (73 18 to 145 146 pg/ml). The
synthesis of PGE2 to JM glomeruli increased significantly from
20 9 to 450 171 (P < 0.05), similar to the response observed
in SP glomeruli.
Arachidonic acid at a concentration of 3.2 X M.
Superfusion of SP glomeruli with 3.2 x i0 M AA resulted in a
significant increase in renin release from 3.4 0.6 to 11.9 3.7
ng Al/ml/hr, (P < 0.05, N = 5). This was accompanied by a
significant threefold increase in 6-keto-PGF1a synthesis from
101 48 to 302 115 pg/ml (P < 0.025) and an increase in PGE2
synthesis from 111 39 to 539 330 pg/mI (P < 0.05).
Superfusion of the JM glomeruli with the same concentration
of arachidonic acid had no effect on the release of renin (1.5
0.8 to 2.0 0.5 ng Al/ml/hr, N = 5). However 6-keto-PGF1a
synthesis was increased from 104 32 to 197 48 pg/mI (P <
0.05), and the synthesis of PGE2 increased in JM glomeruli from
68 26 to 235 90 pg/ml (P < 0.05).
Arachidonic acid at a concentration of 1.6 x 10 M.
Superfusion of SP glomeruli with 1.6 x i0 M arachidonic acid
resulted in a significant increase in renin release from 3.9 2.0
to 24.9 5.1 ng Al/ml/hr (P < 0.005, N = 6). This was
accompanied by a significant increase in 6-keto-PGF1a produc-
tion from 64 20 to 894 209 pg/ml (P < 0.01) and also in
PGE2 synthesis from 62 20 to 545 214 pg/mI (P < 0.05).
Superfusion of JM glomeruli with the same concentration of
arachidonic acid produced the only significant increase in renin
concentration from this glomerular population, changing from
1.1 0.2 to 6.4 0.9 ng Al/mllhr (P < 0.05). Coincident to this
was an increase in 6-keto-PGF1a from 52 10 to 809 154
pg/mI (P < 0.005). Also, PGE2 concentration was increased
from 42 23 to 545 140 pg/ml in JM glomeruli (P < 0.05).
In SP glomeruli, there was a significant correlation between
the release of renin and the synthesis of 6-keto-PGF1a (r 0.83,
P < 0.05) as shown in Figure 4. In the JM glomeruli no
correlation test was performed between renin and 6-keto-PGF1a
since renin release and synthesis of 6-keto-PGF1a were signifi-
cantly enhanced only at the highest perfused dose of AA.
No correlation could be demonstrated between renin release
and the production of PGE2 in either SP or JM glomeruli, since
all three concentrations of AA evoked maximal responses in
PGE2 synthesis (Fig. 3). In agreement with these latter results is
the fact that lower concentrations of AA (1.6 x 10-6 M and 1.6
x i0 M), as well, evoked similar increases in the synthesis of
PGE2 (from 117 10 to 360 30 and from 196 34 to 500
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Fig. 4. Correlation between increments of 6-keto-PGF1 (ordinate) and
renin concentration (abscissa) after administration of increasing doses
of AA (1.6 X iO to 1.6 x I0) to superficial giomeruii. Each circle
represents averaged responses in three to four chambers from glomeruli
isolated in one dog.
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160 pg/mi; average range, N = 2) but failed to induce any
significant changes in renin release or 6-keto-PGF1a in either SP
or JM glomeruli.
In two experiments the administration of meclofenamate, a
cyclooxygenase inhibitor resulted in a complete blockade of
POE2, 6-keto-PGF1a, and renin release when the glomeruli
were perfused with 3.2 >( i04 M AA.
Renin content in superficial and juxtamedullary glomeruli
The amount of angiotensin generated in the incubation of SP
glomeruli homogenate with renin substrate was higher (6.3
0.9 nglml/min) than that obtained from JM glomeruli (3.9 0.1
ng!ml/min).
Synthesis profile of glomerular prostaglandin synthesis
Incubation of SP and JM glomerular homogenates with [1-
'4C] arachidonic acid resulted in approximately 2 to 3% conver-
sion to specific prostaglandins. As shown in Figure 5, there
were no differences in the distribution of the various cyclooxy-
genase products between SP and JM glomeruli. Prostacyclin, as
determined by its stable metabolite, 6-keto-PGF1a appears to be
the primary prostaglandin synthesized, accounting for more
than half of the PG formed in both populations of glomeruli.
Discussion
The results of this study show that the administration of AA
to SP and JM glomeruli produced a comparable increase in the
synthesis of 6-keto-PGF1 in a dose-dependent manner within a
concentration range of 1.6 x iO to 1.6 x lO M. These
increased levels of 6-keto-PGF1a may be best interpreted as
reflecting a proportional enhancement in the synthesis of P012.
Studies conducted by other investigators, however, have
shown that the kidney contains 9-hydroxyprostaglandin dehy-
drogenase capable of converting PG!2 to 6-keto-PGE1 [121. The
relative amount of 6-keto-PGE1 and 6-keto-PGF1 that can be
produced in the kidney from a given amount of P012 is
unknown; hence, the amount of P012 synthesized in our
glomerular preparation could have been proportionally greater
than that reflected by the increased concentration of 6-keto-
PGF1a detected in the perfusion effluent.
The administration of AA also elicited an increase in the
synthesis of PGE2 which, like 6-keto-PGF1a, was not different
between SP and JM glomeruli. However, there was a major
difference in the AA-induced PGE2 responses with respect to 6-
keto-PGF1a in that at a concentration range of AA of 1.6 X 10"
to 1.6 x l0- M evoked a maximal POE2 increase as did lower
concentrations of AA, that is, 1.6 x 106 and 1.6 X l05M.ThiS
would indicate that SP and JM glomeruli have similar capabili-
ties of synthesizing PGE2 and PG!2 in the presence of AA,
although the threshold of PGE2 production is much lower than
that of PGI2.
It should be stated that the different threshold of AA-
stimulation for PGE2 and 6-keto-PGF1a is not a specific phe-
nomenon of dog glomeruli since it has also been found in
isolated rat glomeruli where the synthesis of PGE2 occurred
with a dose of AA which was much lower than the dose needed
to stimulate 6-keto-PGF1a synthesis [61. Similarly Folkert and
Schlondorf [13] and Sraer et al [14] have reported that in
isolated whole rat glomeruli the conversion of AA to POE2 and
PGF2 was much higher than 6-keto-PGF1a. Furthermore,
6-keto PGF1 F2 Tx 62 E + A
Fig. S. Profiles of PG synthesis derived from incubation of superficial
(open bars) and juxtamedullary (hatched bars) glomeruli (N = 4) with
[1-"C] arachidonic acid.
Petrulis, Aikawa, and Dunn [15] found that production of POE2
was higher than 6-keto-PGF1 in explants of whole isolated
glomeruli after 9 days of growth in culture media containing a
large proportion of epithelial cells. The physiological signifi-
cance of this pattern of PG production is difficult to assess. It is
conceivable that the molecules of AA contained in the perfusate
influenced first the cells of the Bowman capsule or the visceral
epithelium located on the tubular side of the glomerulus;
whereas PG synthesis in intraglomerular endothelial cells and
mesangial cells does not occur until AA has diffused through the
glomerular basement membrane. Kreisberg, Karnovsky, and
Levine [16] found that homogenous tissue cultures of glomeru-
lar epithelial cells produced ten times more cyclooxygenase
products than mesangial cells. However, the major product
synthesized by glomerular epithelial cells was PG!2 (90%) while
PGE2 sythesis was the dominant prostanoid synthesized in
mesangial elements (60%). This latter observation is at odds
with the abundance of POE2 that we [6] and others found [13—
15]. !t is apparent to us that the findings of Kreisberg, Kar-
novsky, and Levine [16] cannot be readily contrasted with ours
because PG synthesis in cultured cells appears to be affected by
growth conditions and the number of cell generations. At any
rate, our study was not designed to identify the type of cell
responsible for a predominant production of a particular pros-
tanoid, but rather to see if, under predefined experimental
conditions, there is a difference in PG release between SP and
JM glomeruli. Within this conceptual frame, the similar re-
sponses obtained in superfusion experiments between SP and
JM isolated glomeruli agree with the results of the prostaglandin
profile determined in homogenates of the glomerular prepara-
tions by the conversion of [14CI AA.
As shown in Figure 5, the average amount of prostaglandins
synthesized from [l-14C] AA in SP glomeruli is very similar to
that found in JM glomeruli. These results agree with those
reported by Okahara, Imanishi, and Yamamoto [17] who also
failed to demonstrate any significant difference in the synthesis
of prostaglandin by superficial and juxtamedullary renal cortical
slices.
Despite the comparable ability of SP and JM glomeruli to
synthesize similar amounts of POE2 and 6-keto-PGF1a, when
superfused with AA they exhibited significant differences in
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their capacity to release renin. Renin concentration in the
effluent of the SP glomeruli increased in proportion to the
concentration of perfused AA. However, in JM glomeruli, a
significant increase in renin release was seen only at the highest
concentration of AA, which was one third of the renin released
in SP effluent at this concentration (that is, 1.6 X i0 M). To a
large extent, this could be due to the reported existence of a
cortical gradient of renin which is higher in SP than in JM
glomeruli. Brown et al [181 and de Rouffignac, Bonvalent, and
Menard [19] reported that renin content of glomeruli from the
superficial cortex is much higher than that found in juxtame-
dullary glomeruli. Jones et al [20] observed in the cat that
plasma renin activity was higher in renal superficial cortical
veins which drain the superficial glomeruli than in the hilar
veins known to drain blood from JM glomeruli. The increments
in renin secretion induced by AA were significantly correlated
with the increase in the synthesis of 6-keto-PGF1,; whereas no
correlation was observed between renin and PGE2 synthesis.
This would indicate PGI2 rather than PGE2 is responsible for
stimulating renin release in these glomeruli and further support
our previous work in rat glomeruli [6] as well as other investiga-
tory work in rabbit cortical slices [21] and systemically in
humans [22]. In addition, the meclofenamate blockade of PG
synthesis suggests renin release depends on PG synthesis rather
than a direct affect of AA.
In summary, the results of this study do not support the
existence of glomerular heterogenicity with respect to their
ability to synthesize PGE2 and P012 from AA; but they do
advocate a heterogeneous ability to release renin. Furthermore,
renin release by these glomeruli appears to be stimulated by
PGI2 synthesis rather than PGE2 synthesis.
Acknowledgments
Portions of this work were presented at the 1981 meeting of the
American Physiological Society in Cleveland, Ohio. This study was
supported by grants from the National Institutes of Health, American
Heart and Lung Institute (HL-16496), and the Mayo Foundation. The
study was performed during Dr. J. C. Romero's tenure as an Estab-
lished Investigator of the American Heart Association and when Dr. W.
H. Beierwaltes was a postdoctoral fellow supported by Hypertension
Training grant HL07269. The authors thank D. Stender for technical
assistance and B. Becker for secretarial assistance.
Reprint requests to Dr. J. C. Romero, Department of Physiology and
Biophysics, Mayo Clinic Foundation, Rochester, Minnesota 55905,
USA
References
1. VALTIN H: Structural and functional heterogeneity of mammalian
nephrons. Am J Physiol 233:F49l—F501, 1977
2. BRENNER BM, BADR KF, SCHOR N, ICHIKAWA I: Hormonal
influences on glomerular filtration. Miner Electrolyte Metab 4:49—
56, 1980
3. BAER PG, MCGIFF JC: Hormonal system and renal hemodynamics
(abstract). Am Rev Physiol 42:589, 1980
4. BLANTZ RC: Segmental renal vascular resistance: Simple nephron.
Am Rev Physiol 42:573—580, 1980
5. BEIERWALTES WH, SCHRYVER 5, OLSON PS, ROMERO JC: Interac-
tion of the prostaglandin and renin-angiotensin systems in isolated
rat glomeruli. Am J Physiol 239:F602—F608, 1980
6. BEIERWALTES WH, SCHRYVER 5, SANDERS E,STRAND J, ROMERO
JC: Renin release selectively stimulated by prostaglandin 12 in
isolated rat glomeruli. Am J Physiol 243:F276—F283, 1982
7. Motuus BJ, NIXON RL, JOHNSON CI: Release of renin from
glomeruhi isolated from rat kidney. Clin Exp Pharmacol Physiol
224:1415—1519, 1973
8. Romero JC, Hoobler SW: Changes in renin kinetics induced by
nephrectomy. Am J Physiol 223:1076—1080, 1972
9. LAZAR J, ROMERO JC, HOOBLER SW: Renin kinetics in experimen-
tal renal hypertension. Am J Physiol 220:191—195, 1971
10. STRAND JC, EDWARDS BS, ANDERSON ME, ROMERO JC, KNOX
FG: Effect of imidazole on renal function in unilateral obstructed
rat kidneys. Am J Physiol 240:F508—F5l4, 1981
11. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein
measurement with the Folin phenol reagent. J Biol Chem 193:265—
275, 1951
12. WONG PY-K, MCGIFF JC, CAGEN L, MALIK KU, SUN FF:
Metabolism of prostacyclin in the rabbit kidney. J Biol Chem
254:12—14, 1979
13. FOLKERT V, SCHLONDORF D: Prostaglandin synthesis in isolated
glomeruli. Prostaglandins 17:79—86, 1979
14. SRAERJ, SIESS W, MOULONGUET-DOLERIS L, OUDINETJ, DRAY F,
ARDAILLOU R: In vitro prostaglandin synthesis by various rat renal
preparations. Biochem Biophys Acta 710:45—52, 1982
15. PETRULIS AS, AIKAWA M, DUNN MJ: Prostaglandin and throm-
boxane synthesis by rat glomerular epithelial cells. Kidney mt
20:469—474, 1981
16. KREISBERG JI, KARNOVSKY MJ, LEVINE L: Prostaglandin produc-
tion by homogeneous cultures of rat glomerular epithelial and
mesangial cells. Kidney mt 22:355—359, 1982
17. OKAHARA T, IMANISHI M, YAMAMOTO K: Biosynthesis of prosta-
glandins and thromboxanes in the dog kidney, in Prostaglandins
and the Kidney: Biochemistry, Pharmacology, and Clinical As-
pects, edited by PATRONO C, DUNN MJ, CIN0TTI GA, New York,
Plenum Publishing Corporation, 1980, pp 53—60
18. BROwN JJ, DAVIES DL, LEVER AF, PARKER RA, ROBERTSON JIS:
The assay of renin in single glomeruli in the normal rabbit and the
appearance of the juxtaglomerular apparatus. J Physiol (Lond)
176:418—428, 1965
19. DE ROUFFIGNAC C, BONVALENT JP, MENARD J: Renin content in
superficial and deep glomeruli of normal and salt-loaded rats. Am J
Physiol 226:150—154, 1974
20, JONES SM, TORETH J, WILLIAMS JS, WEINBURGER SF: Regional
renin release by the cat kidney in vitro and in vivo. Am J Physiol
237:Fl88—F194, 1979
21. WI-IORTON AR, MISONOK K, HOLLIFIELD J, FROLICH JC, INAGAMI
T, OATES JA: Prostaglandins and renin release: I. Stimulation of
renin release from rabbit renal cortical slices by PG!2 (abstract).
Prostaglandins 14:1095, 1978
22. PATRONO C, PUGLIE5E F, CIABATTONI G, PATRIGNANI P. MASERI
A, CHIERCHIA S, PESKAR B, CINOTTI GA, SIMONETTI B, PIERUCCI
A: Evidence for a direct stimulatory effect of prostacyclin on renin
release in man. Am Soc Clin Invest 69:23 1—239, 1982
